- HK$6.82bn
- HK$5.27bn
- CNY3.39bn
- 44
- 19
- 48
- 26
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,838 | 2,848 | 2,703 | 3,431 | 3,389 |
Cost of Revenue | |||||
Gross Profit | 1,772 | 1,532 | 1,226 | 1,835 | 2,068 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,309 | 2,767 | 3,661 | 3,999 | 3,409 |
Operating Profit | 529 | 80.6 | -958 | -568 | -20.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 545 | 107 | -956 | -560 | -30.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 513 | 55.8 | -917 | -574 | -65.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 347 | 9.14 | -864 | -553 | -83 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 347 | 9.14 | -864 | -553 | -83 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.16 | 0.068 | -1.82 | -1.17 | -0.15 |